{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:03:58Z","timestamp":1795089838184,"version":"4.10.2"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>High-grade serous ovarian cancer (HGSOC) is the biggest cause of gynecological cancer-related mortality because of its extremely metastatic nature. This study aimed to explore and evaluate the characteristics of candidate factors associated with the metastasis and progression of HGSOC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Transcriptomic data of HGSOC patients' samples collected from primary tumors and matched omental metastatic tumors were obtained from three independent studies in the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were selected to evaluate the effects on the prognosis and progression of ovarian cancer using data from The Cancer Genome Atlas (TCGA) database. Hub genes' immune landscapes were estimated by the Tumor Immune Estimation Resource (TIMER) database. Finally, using 25 HGSOC patients' cancer tissues and 10 normal fallopian tube tissues, immunohistochemistry (IHC) was performed to quantify the expression levels of hub genes associated with International Federation of Gynecology and Obstetrics (FIGO) stages.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Fourteen DEGs, <jats:italic toggle=\"yes\">ADIPOQ<\/jats:italic>, <jats:italic toggle=\"yes\">ALPK2<\/jats:italic>, <jats:italic toggle=\"yes\">BARX1<\/jats:italic>, <jats:italic toggle=\"yes\">CD37<\/jats:italic>, <jats:italic toggle=\"yes\">CNR2<\/jats:italic>, <jats:italic toggle=\"yes\">COL5A3<\/jats:italic>, <jats:italic toggle=\"yes\">FABP4<\/jats:italic>, <jats:italic toggle=\"yes\">FAP<\/jats:italic>, <jats:italic toggle=\"yes\">GPR68<\/jats:italic>, <jats:italic toggle=\"yes\">ITGBL1<\/jats:italic>, <jats:italic toggle=\"yes\">MOXD1<\/jats:italic>, <jats:italic toggle=\"yes\">PODNL1<\/jats:italic>, <jats:italic toggle=\"yes\">SFRP2<\/jats:italic>, and <jats:italic toggle=\"yes\">TRAF3IP3<\/jats:italic>, were upregulated in metastatic tumors in every database while <jats:italic toggle=\"yes\">CADPS<\/jats:italic>, <jats:italic toggle=\"yes\">GATA4<\/jats:italic>, <jats:italic toggle=\"yes\">STAR<\/jats:italic>, and <jats:italic toggle=\"yes\">TSPAN8<\/jats:italic> were downregulated. <jats:italic toggle=\"yes\">ALPK2<\/jats:italic>, <jats:italic toggle=\"yes\">FAP<\/jats:italic>, <jats:italic toggle=\"yes\">SFRP2<\/jats:italic>, <jats:italic toggle=\"yes\">GATA4<\/jats:italic>, <jats:italic toggle=\"yes\">STAR<\/jats:italic>, and <jats:italic toggle=\"yes\">TSPAN8<\/jats:italic> were selected as hub genes significantly associated with survival and recurrence. All hub genes were correlated with tumor microenvironment infiltration, especially cancer-associated fibroblasts and natural killer (NK) cells. Furthermore, the expression of <jats:italic toggle=\"yes\">FAP<\/jats:italic> and <jats:italic toggle=\"yes\">SFRP2<\/jats:italic> was positively correlated with the International Federation of Gynecology and Obstetrics (FIGO) stage, and their increased protein expression levels in metastatic samples compared with primary tumor samples and normal tissues were confirmed by IHC (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0002 and <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0001, respectively).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>This study describes screening for DEGs in HGSOC primary tumors and matched metastasis tumors using integrated bioinformatics analyses. We identified six hub genes that were correlated with the progression of HGSOC, particularly <jats:italic toggle=\"yes\">FAP<\/jats:italic> and <jats:italic toggle=\"yes\">SFRP2<\/jats:italic>, which might provide effective targets to predict prognosis and provide novel insights into individual therapeutic strategies for HGSOC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000002328","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T14:01:18Z","timestamp":1686146478000},"page":"2974-2982","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":27,"title":["Characterization of candidate factors associated with the metastasis and progression of high-grade serous ovarian cancer"],"prefix":"10.1097","volume":"136","author":[{"given":"Huiping","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China"},{"name":"Center of Gynecologic Oncology, Peking University People's Hospital, Beijing 100044, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China"},{"name":"Center of Gynecologic Oncology, Peking University People's Hospital, Beijing 100044, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China"},{"name":"Center of Gynecologic Oncology, Peking University People's Hospital, Beijing 100044, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China"},{"name":"Center of Gynecologic Oncology, Peking University People's Hospital, Beijing 100044, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Luan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China"},{"name":"Center of Gynecologic Oncology, Peking University People's Hospital, Beijing 100044, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China"},{"name":"Center of Gynecologic Oncology, Peking University People's Hospital, Beijing 100044, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China"},{"name":"Center of Gynecologic Oncology, Peking University People's Hospital, Beijing 100044, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China"},{"name":"Center of Gynecologic Oncology, Peking University People's Hospital, Beijing 100044, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China"},{"name":"Center of Gynecologic Oncology, Peking University People's Hospital, Beijing 100044, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China"},{"name":"Center of Gynecologic Oncology, Peking University People's Hospital, Beijing 100044, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China"},{"name":"Center of Gynecologic Oncology, Peking University People's Hospital, Beijing 100044, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"R1-20250602","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20250602","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3322\/caac.21559","article-title":"Epithelial ovarian cancer: Evolution of management in the era of precision medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R3-20250602","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-pathol-020712-163949","article-title":"Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma","volume":"9","author":"Nik","journal-title":"Annu Rev Pathol 2014"},{"key":"R4-20250602","doi-asserted-by":"crossref","first-page":"599915","DOI":"10.3389\/fonc.2020.599915","article-title":"How autophagy shapes the tumor microenvironment in ovarian cancer","volume":"10","author":"Ferraresi","year":"2020","journal-title":"Front Oncol"},{"key":"R5-20250602","doi-asserted-by":"crossref","first-page":"C444","DOI":"10.1152\/ajpcell.00188.2015","article-title":"Cellular and molecular processes in ovarian cancer metastasis. A review in the theme: Cell and molecular processes in cancer metastasis","volume":"309","author":"Yeung","year":"2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"R6-20250602","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ygyno.2020.12.033","article-title":"Is routine omentectomy of grossly normal omentum helpful in surgery for ovarian cancer? A look at the tumor microenvironment and its clinical implications","volume":"161","author":"Bilbao","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R7-20250602","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am J Pathol"},{"key":"R8-20250602","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat Biotechnol"},{"key":"R9-20250602","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/ERC-11-0329","article-title":"Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients","volume":"19","author":"Gyorffy","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"R10-20250602","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"R11-20250602","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","journal-title":"Nat Rev Cancer 2015"},{"key":"R12-20250602","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10555-020-09935-1","article-title":"The role of caspase-8 in the tumor microenvironment of ovarian cancer","volume":"40","author":"Kostova","journal-title":"Cancer Metastasis Rev 2021"},{"key":"R13-20250602","first-page":"2885","article-title":"An evolving story of the metastatic voyage of ovarian cancer cells: Cellular and molecular orchestration of the adipose-rich metastatic microenvironment","volume":"38","author":"Motohara","journal-title":"Oncogene 2019"},{"key":"R14-20250602","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2017.00024","article-title":"The unique molecular and cellular microenvironment of ovarian cancer","volume":"7","author":"Worzfeld","year":"2017","journal-title":"Front Oncol"},{"key":"R15-20250602","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.3390\/ijms20102401","article-title":"The crowded crosstalk between cancer cells and stromal microenvironment in gynecological malignancies: Biological pathways and therapeutic implication","volume":"20","author":"De Nola","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R16-20250602","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13048-019-0596-z","article-title":"Wnt\/\u03b2-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis","volume":"12","author":"Nguyen","year":"2019","journal-title":"J Ovarian Res"},{"key":"R17-20250602","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3390\/jcm8101658","article-title":"Wnt signaling in ovarian cancer stemness, EMT, and therapy resistance","volume":"8","author":"Teeuwssen","year":"2019","journal-title":"J Clin Med"},{"key":"R18-20250602","doi-asserted-by":"crossref","first-page":"537","DOI":"10.7150\/thno.37423","article-title":"WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer","volume":"10","author":"Kotrbov\u00e1","year":"2020","journal-title":"Theranostics"},{"key":"R19-20250602","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.3390\/ijms21124272","article-title":"Wnt signaling in gynecologic malignancies","volume":"21","author":"McMellen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R20-20250602","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00262-019-02445-2","article-title":"IL-17A promotes fatty acid uptake through the IL-17A\/IL-17RA\/p-STAT3\/FABP4 axis to fuel ovarian cancer growth in an adipocyte-rich microenvironment","volume":"69","author":"Yu","journal-title":"Cancer Immunol Immunother 2020"},{"key":"R21-20250602","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41419-019-2221-x","article-title":"SIK2 enhances synthesis of fatty acid and cholesterol in ovarian cancer cells and tumor growth through PI3K\/Akt signaling pathway","volume":"11","author":"Zhao","year":"2020","journal-title":"Cell Death Dis"},{"key":"R22-20250602","first-page":"1498","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","journal-title":"Nat Med 2011"},{"key":"R23-20250602","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.3390\/cancers11121870","article-title":"Ovarian cancer-why lipids matter","volume":"11","author":"Zhao","year":"2019","journal-title":"Cancers (Basel)"},{"key":"R24-20250602","doi-asserted-by":"crossref","first-page":"599995","DOI":"10.3389\/fonc.2021.599995","article-title":"PPAR-\u03b1 modulators as current and potential cancer treatments","volume":"11","author":"Tan","year":"2021","journal-title":"Front Oncol"},{"key":"R25-20250602","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1158\/0008-5472.CAN-19-1999","article-title":"Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance","volume":"80","author":"Mukherjee","year":"2020","journal-title":"Cancer Res"},{"key":"R26-20250602","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3390\/ijms18020474","article-title":"Next-generation sequencing approach in methylation analysis of HNF1B and GATA4 genes: Searching for biomarkers in ovarian cancer","volume":"18","author":"Bubancova","year":"2017","journal-title":"Int J Mol Sci"},{"key":"R27-20250602","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1515\/cclm-2019-1319","article-title":"Identification of a four-gene methylation biomarker panel in high-grade serous ovarian carcinoma","volume":"58","author":"Baranova","journal-title":"Clin Chem Lab Med 2020"},{"key":"R28-20250602","first-page":"232","article-title":"StAR and progesterone producing enzymes (3beta-hydroxysteroid dehydrogenase and cholesterol side-chain cleavage cytochromes P450) in human epithelial ovarian carcinoma: Immunohistochemical and real-time PCR studies","volume":"96","author":"Abd-Elaziz","journal-title":"Cancer Sci 2005"},{"key":"R29-20250602","first-page":"4540","article-title":"Therapeutic targeting of tetraspanin8 in epithelial ovarian cancer invasion and metastasis","volume":"35","author":"Park","journal-title":"Oncogene 2016"},{"key":"R30-20250602","first-page":"2301","article-title":"ALPK2 is crucial for luminal apoptosis and DNA repair-related gene expression in a three-dimensional colonic-crypt model","volume":"32","author":"Yoshida","year":"2012","journal-title":"Anticancer Res"},{"key":"R31-20250602","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12935-020-01347-z","article-title":"Knockdown of ALPK2 inhibits the development and progression of ovarian cancer","volume":"20","author":"Zhu","year":"2020","journal-title":"Cancer Cell Int"},{"key":"R32-20250602","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1186\/s12885-020-07541-6","article-title":"High expression of fibroblast activation protein (FAP) predicts poor outcome in high-grade serous ovarian cancer","volume":"20","author":"Li","year":"2020","journal-title":"BMC Cancer"},{"key":"R33-20250602","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12307-014-0153-7","article-title":"Stromal expression of fibroblast activation protein alpha (FAP) predicts platinum resistance and shorter recurrence in patients with epithelial ovarian cancer","volume":"8","author":"Mhawech-Fauceglia","year":"2015","journal-title":"Cancer Microenviron"},{"key":"R34-20250602","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10555-020-09941-3","article-title":"Secreted frizzled-related protein 2: A key player in noncanonical Wnt signaling and tumor angiogenesis","volume":"40","author":"van Loon","journal-title":"Cancer Metastasis Rev 2021"},{"key":"R35-20250602","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ygyno.2019.06.010","article-title":"Genes associated with bowel metastases in ovarian cancer","volume":"154","author":"Mariani","journal-title":"Gynecol Oncol 2019"},{"key":"R36-20250602","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: Functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"R37-20250602","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.3389\/fimmu.2018.01990","article-title":"Positive & negative roles of innate effector cells in controlling cancer progression","volume":"9","author":"Stolk","year":"2018","journal-title":"Front Immunol"},{"key":"R38-20250602","first-page":"214","article-title":"Implications of the tumor immune microenvironment for staging and therapeutics","volume":"31","author":"Taube","journal-title":"Mod Pathol 2018"},{"key":"R39-20250602","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.canlet.2015.07.039","article-title":"Tumor microenvironment: Sanctuary of the devil","volume":"368","author":"Hui","year":"2015","journal-title":"Cancer Lett"},{"key":"R40-20250602","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","journal-title":"Nat Rev Clin Oncol 2017"},{"key":"R41-20250602","doi-asserted-by":"crossref","first-page":"101417","DOI":"10.1016\/j.smim.2020.101417","article-title":"Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies","volume":"48","author":"Mhaidly","year":"2020","journal-title":"Semin Immunol"},{"key":"R42-20250602","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1084\/jem.20180765","article-title":"Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer","volume":"216","author":"Gao","year":"2019","journal-title":"J Exp Med"},{"key":"R43-20250602","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.3389\/fimmu.2019.01782","article-title":"Naturally killing the silent killer: NK cell-based immunotherapy for ovarian cancer","volume":"10","author":"Nersesian","year":"2019","journal-title":"Front Immunol"},{"key":"R44-20250602","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3390\/cancers13030405","article-title":"Understanding and targeting natural killer cell-cancer-associated fibroblast interactions in pancreatic ductal adenocarcinoma","volume":"13","author":"Malchiodi","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002328","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T19:05:37Z","timestamp":1748891137000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":44,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000002328","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]},"assertion":[{"value":"2022-12-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}